These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36376238)

  • 1. Delay in desmopressin therapy: Disaster in waiting.
    Kroll C; Zandvakili A
    J Clin Pharm Ther; 2022 Dec; 47(12):2376-2378. PubMed ID: 36376238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic central diabetes insipidus presenting in a very low birth weight infant successfully managed with lyophilized sublingual desmopressin.
    Hanta D; Törer B; Temiz F; Kılıçdağ H; Gökçe M; Erdoğan Ö
    Turk J Pediatr; 2015; 57(1):90-3. PubMed ID: 26613228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
    Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central Diabetes Insipidus in a Preterm Neonate Unresponsive to Intranasal Desmopressin.
    Hussain A; Baier RJ; Mehrem AA; Soylu H; Fraser D; Elsayed Y
    Neonatal Netw; 2020 Nov; 39(6):339-346. PubMed ID: 33318230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
    Smego AR; Backeljauw P; Gutmark-Little I
    J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patient with essential hypernatremia had good response to desmopressin acetate therapy.
    Guo Q; Lu J; Mu Y; Dou J; Pan C
    Neuro Endocrinol Lett; 2010; 31(5):588-93. PubMed ID: 21173753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Persistent central diabetes insipidus in a very low birth weight infant].
    Quetin F; Garnier H; Brauner R; Vodovar M; Magny JF
    Arch Pediatr; 2007 Nov; 14(11):1321-3. PubMed ID: 17916426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of central diabetes insipidus.
    Garrahy A; Thompson CJ
    Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101385. PubMed ID: 32169331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival with serum sodium level of 180 mEq/L: permanent disorientation to place and time.
    Gomez-Daspet J; Elko L; Grebenev D; Vesely DL
    Am J Med Sci; 2002 Dec; 324(6):321-5. PubMed ID: 12495299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
    Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
    Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of transient central diabetes insipidus with intravenous desmopressin in a premature infant with gastroschisis and septo-optic dysplasia: A case report.
    Kim F; Towers HM
    J Neonatal Perinatal Med; 2021; 14(2):293-297. PubMed ID: 32804104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permanent central diabetes insipidus after traumatic brain injury. Case report and literature review.
    Astafyeva LI; Sidneva YG; Badmaeva IN; Kalinin PL; Latyshev YA; Marshintsev AV; Valiullina SA
    Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(5):112-118. PubMed ID: 36252201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central diabetes insipidus following carbon monoxide poisoning.
    Chang MY; Lin JL
    Am J Nephrol; 2001; 21(2):145-9. PubMed ID: 11359023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in Oral Desmopressin Dose Requirements in Children with Central Diabetes Insipidus.
    Almutlaq N; Eugster EA
    J Pediatr; 2021 Dec; 239():228-230. PubMed ID: 34487771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypernatremia and polyuria in a female patient with an initial diagnosis of secondary acute myeloid leukemia].
    Aydilek E; Jäger K; Xhaxho K; Akdas R; Wallbach M; Wulf G; Brökers N
    Inn Med (Heidelb); 2022 Nov; 63(11):1194-1199. PubMed ID: 35925122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
    Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
    Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with sublingual desmopressin in two infants with hydranencephaly and central diabetes insipidus].
    Marín GR; Baspineiro B; Vilca I
    Arch Argent Pediatr; 2018 Feb; 116(1):e93-e97. PubMed ID: 29333830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous formulation of desmopressin delivered via oral and g tube routes for the treatment of central diabetes insipidus: First experience in infants.
    Lim WY; Riba-Wolman R
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):179-181. PubMed ID: 31715009
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetes insipidus and pregnancy.
    Chanson P; Salenave S
    Ann Endocrinol (Paris); 2016 Jun; 77(2):135-8. PubMed ID: 27172867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurosarcoidosis-associated central diabetes insipidus masked by adrenal insufficiency.
    Non L; Brito D; Anastasopoulou C
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25612752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.